Investor Slate Path Capital LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Slate Path Capital LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13G TVRD / Tvardi Therapeutics, Inc. 704,118
2025-02-14 13G/A CUE / Cue Biopharma, Inc. 2,402,455 918,836
2024-12-06 13G/A CYCN / Cyclerion Therapeutics, Inc. 357,880 0
2024-01-22 13G/A CYCN / Cyclerion Therapeutics, Inc. 357,880
2023-02-14 13G/A SFIX / Stitch Fix, Inc. 4,282,056 0
2023-02-14 13G CUE / Cue Biopharma, Inc. 2,402,455 2,402,455
2023-01-13 13G CYCN / Cyclerion Therapeutics, Inc. 7,157,601 7,157,601
2022-11-18 13G CUE / Cue Biopharma, Inc. 2,402,455
2022-10-21 13D CYCN / Cyclerion Therapeutics, Inc. 7,157,601 7,157,601
2022-02-14 13G US9895701061 / Zimmer Energy Transition Acquisition Corp., Class A 2,000,000
2022-02-11 13G HIPO / Hippo Holdings Inc. 1,750,000 350,000
2022-02-11 13G/A WMG / Warner Music Group Corp. 4,490,000 3,134,779
2022-02-11 13G FVAM / 5:01 Acquisition Corp. 500,000
2022-02-11 13G/A CYCN / Cyclerion Therapeutics, Inc. 6,196,063 7,157,601
2022-02-11 13G SFIX / Stitch Fix, Inc. 4,282,056
2021-02-16 13G HIPO / Hippo Holdings Inc. 1,750,000
2021-02-16 13G WMG / Warner Music Group Corp. 4,490,000
2020-08-10 13G CYCN / Cyclerion Therapeutics, Inc. 6,196,063